SK Hynix's Billion-Won Balancing Act: A $38 Billion Capacity Bet Meets a Market Testing Its Nerves
Published on 08/13/2026 at 03:32 | Redaktion boerse-global.de
The numbers coming out of SK Hynix this summer are the kind that make investors stop and re-read the screen. Revenue up 257 percent year on year. Operating profit at a record 60.5 trillion won. A capital spending plan worth 54.3 trillion won — roughly $38.3 billion — approved by the board in early August for two new fabrication plants. And yet the stock, after shedding a fifth of its value in a single month, needed a 5.5 percent bounce on one Wednesday just to regain its footing.
That Wednesday's rebound, which lifted the shares to 1,504,000 won, came on the back of a strategic shift that is reshaping the company's geography. SK Hynix confirmed it is exploring the sale of a stake in its NAND packaging and testing facility in Chongqing, China — a move that could bring in around $3 billion — even as it pushes ahead with a $3.87 billion plant in West Lafayette, Indiana, backed by $450 million in CHIPS Act funding. The ground-breaking for that US facility is set for August 27.
The two tracks are not coincidence; they are the architecture of a deliberate rebalancing. Capital is being redirected from commodity NAND production in China toward the high-margin AI memory products — HBM4E and beyond — that have made SK Hynix the dominant supplier in the high-bandwidth memory market, where it holds a 57 percent share according to Cantor Fitzgerald. First samples of the upgraded 12-layer HBM4E chips have already gone out to marquee customers such as Nvidia.
A Spending Plan That Answers Its Own Critics
The investment blueprint approved in early August is the clearest statement of intent. The Y2 DRAM fab in Yongin accounts for 35.2 trillion won of the total, while the M17 NAND facility in Cheongju takes 19.1 trillion won. Both are scheduled to come online by 2031, and the company's rationale is blunt: AI-driven demand for memory chips is growing faster than even a company of this scale can keep up with using existing capacity.
The analyst community has largely bought into the thesis. RBC Capital initiated coverage with an "Outperform" rating and a $200 price target, while Stifel followed with a "Buy" and $240 target. Both cited a multi-year memory upcycle powered by generative AI that they expect to run through 2027.
Should investors sell immediately? Or is it worth buying SK Hynix?
The second-quarter results, reported for the period ending June 2026, gave that thesis its empirical backing — with a caveat. Revenue of 79.3 trillion won represented that 257 percent surge, and operating profit climbed 557 percent to the record 60.5 trillion won. But revenue came in slightly below analyst expectations, as the legacy DRAM business underperformed. Several houses trimmed their price targets in response.
The Market's Mood Swings
The trading statistics tell the story of a stock that has become a proxy for AI-era volatility. The shares sit roughly 50 percent below their 52-week high of 2,987,000 won, reached as recently as June, yet remain 371 percent above last September's low. The relative strength index of 42.2 suggests no extreme positioning, but the annualized volatility of 147 percent says something else entirely: this is a stock that moves in leaps, not steps. Even after the recent turbulence, it is up 131 percent year to date.
The target cuts have come from multiple directions. Barclays lowered its ADR target from $330 to $300, citing softer price expectations for commodity DRAM. UBS trimmed its target from 3.2 million to 3.0 million won, pointing to revised 2027 earnings forecasts. These adjustments reflect a persistent worry beneath the AI enthusiasm: pricing discipline in the traditional memory business remains fragile.
Side Bets and Capital Returns
Around the core narrative, several subplots are developing. SK Hynix initially denied a Korea Economic Daily report about a possible Nasdaq listing for its US subsidiary Solidigm, then acknowledged in a regulatory filing that Solidigm is reviewing "various options" to strengthen its competitiveness. A pre-IPO funding round of 5 trillion won has also been floated. The company has been similarly circumspect about the Chongqing packaging plant, which media reports value at around 4 trillion won — it is reviewing options, but no sale has been decided.
There is also talk, unconfirmed, that Singapore's sovereign wealth fund Temasek is considering an investment. And the company has moved to keep shareholders onside: a quarterly dividend of 375 won per share was approved with a record date of August 31, and management has promised additional capital return measures to be finalized in the third quarter of 2026.
The Two Scenarios
For the bulls, the pieces align neatly. The board has already committed the capital for Yongin and Cheongju, the HBM4E ramp is underway with Nvidia as an anchor customer, and a Solidigm listing could unlock fresh funding. The structural advantage in AI memory looks intact.
For the bears, the risks are equally concrete. The Chongqing sale is still only an option under review, not a decision. The continued investment in Dalian, where Solidigm operates, carries regulatory exposure to US export controls. Any delay in the China exit — whether from regulatory hurdles or complications in the Dalian expansion — could leave the company with an investment logjam across two continents.
The stock's 27 percent gap below its 50-day moving average suggests the market is not yet convinced the turbulence has passed. The next test comes on August 27, when the Indiana ground-breaking will show whether SK Hynix can execute its two-continent pivot as smoothly on the ground as it does on paper. Third-quarter results, expected October 27, will provide the fuller picture of whether the record profits can hold up against the costs of restructuring.
Ad
SK Hynix Stock: New Analysis - 13 August
Fresh SK Hynix information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
